JP Stock MarketDetailed Quotes

4551 Torii Pharmaceutical

Watchlist

3815
+85+2.28%

20min DelayMarket Closed Jul 12 15:00 JST

109.87BMarket Cap26.02P/E (Static)

Torii Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

13.89%13.45B

11.75%54.64B

14.18%15.51B

9.99%13.43B

14.38%13.89B

7.76%11.81B

4.06%48.89B

0.21%13.58B

2.79%12.21B

4.17%12.14B

Cost of revenue

19.07%7.49B

16.97%29.85B

22.83%8.75B

15.49%7.33B

17.35%7.48B

10.84%6.29B

12.66%25.52B

10.28%7.12B

11.35%6.35B

11.92%6.38B

Gross profit

7.99%5.96B

6.04%24.79B

4.61%6.76B

4.06%6.11B

11.12%6.41B

4.44%5.52B

-3.94%23.38B

-8.93%6.46B

-5.11%5.87B

-3.24%5.77B

Operating expense

-23.15%4.58B

10.74%19.75B

-1.06%4.93B

-1.78%4.41B

1.90%4.46B

49.25%5.96B

-9.38%17.83B

-10.88%4.98B

-6.91%4.49B

-9.98%4.38B

Staff costs

-3.97%1.21B

1.88%5.16B

-5.37%1.32B

3.04%1.22B

10.49%1.36B

0.40%1.26B

0.56%5.07B

3.10%1.4B

0.94%1.19B

-3.68%1.23B

Selling and administrative expenses

-11.41%334M

9.95%3.62B

9.70%2.45B

-2.51%388M

14.78%396M

22.40%377M

-21.47%3.29B

60.24%2.24B

-59.80%398M

-64.90%345M

-Selling and marketing expense

-11.41%334M

0.06%1.58B

-20.57%421M

-2.51%388M

14.78%396M

22.40%377M

-62.24%1.58B

-62.03%530M

-59.80%398M

-64.90%345M

-General and administrative expense

----

19.10%2.03B

----

--1.71B

----

Research and development costs

-74.14%532M

110.11%3.49B

18.71%679M

-21.34%398M

-12.53%356M

1,068.75%2.06B

99.64%1.66B

78.19%572M

181.11%506M

82.51%407M

Depreciation and amortization

----

-6.84%218M

----

-9.65%234M

----

-Depreciation

----

-6.84%218M

----

-9.65%234M

----

Other operating expenses

10.55%2.5B

-4.21%7.27B

-52.77%256M

0.08%2.4B

-1.92%2.35B

0.49%2.27B

-18.99%7.59B

-76.01%542M

-3.15%2.4B

0.67%2.39B

Operating profit

417.43%1.38B

-9.09%5.04B

23.76%1.83B

22.99%1.7B

40.14%1.95B

-133.67%-436M

19.02%5.55B

-1.66%1.48B

1.24%1.38B

26.59%1.39B

Net non-operating interest income (expenses)

20.97%75M

71.86%287M

33.93%75M

73.33%78M

157.14%72M

63.16%62M

15.97%167M

69.70%56M

32.35%45M

-34.88%28M

Non-operating interest income

20.97%75M

71.86%287M

33.93%75M

73.33%78M

157.14%72M

63.16%62M

15.97%167M

69.70%56M

32.35%45M

-34.88%28M

Non-operating interest expense

--0

Net investment income

-188.24%-49M

-15.38%11M

6.59%97M

-106.67%-2M

-63.41%-67M

74.63%-17M

-82.89%13M

42.19%91M

114.29%30M

-173.21%-41M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-1,168.42%-241M

121.60%277M

2,193.33%314M

35.71%-9M

-105.20%-9M

0.00%-19M

226.26%125M

0.00%-15M

6.67%-14M

468.09%173M

Income from associates and other participating interests

Special income (charges)

-500.00%-6M

-1,700.00%-36M

-1,600.00%-34M

-1M

94.87%-2M

85.71%-2M

Less:Other special charges

500.00%6M

1,700.00%36M

--34M

--0

--1M

-92.59%2M

----

Other non-operating income (expenses)

-133.33%-2M

116.53%20M

-63.64%4M

-16.67%5M

103.60%5M

500.00%6M

-503.33%-121M

120.00%11M

-25.00%6M

-1,258.33%-139M

Income before tax

386.42%1.16B

-2.25%5.59B

41.06%2.28B

22.21%1.77B

38.04%1.95B

-132.50%-405M

20.03%5.72B

2.60%1.62B

3.20%1.45B

23.92%1.41B

Income tax

342.24%281M

-17.15%1.47B

0.00%529M

11.85%491M

27.58%569M

-131.87%-116M

27.73%1.78B

20.50%529M

6.81%439M

35.56%446M

Net income

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

1.71%1.01B

19.18%963M

Net income continuous operations

404.15%879M

4.46%4.12B

61.03%1.75B

26.71%1.28B

42.89%1.38B

-132.77%-289M

16.86%3.94B

-4.31%1.09B

1.71%1.01B

19.18%963M

Noncontrolling interests

Net income attributable to the company

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

1.71%1.01B

19.18%963M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

1.71%1.01B

19.18%963M

Gross dividend payment

Basic earnings per share

404.18%31.27

4.42%146.6

60.93%62.33

26.74%45.59

42.78%48.96

-132.74%-10.28

16.87%140.39

-4.25%38.73

1.67%35.97

19.19%34.29

Diluted earnings per share

404.18%31.27

4.42%146.6

60.90%62.3016

26.74%45.59

42.65%48.8985

-132.74%-10.28

16.87%140.39

-4.25%38.7202

1.67%35.97

19.15%34.279

Dividend per share

20.00%120

-7.89%70

108.33%50

108.33%100

216.67%76

0.00%24

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	13.89%13.45B	11.75%54.64B	14.18%15.51B	9.99%13.43B	14.38%13.89B	7.76%11.81B	4.06%48.89B	0.21%13.58B	2.79%12.21B	4.17%12.14B
Cost of revenue	19.07%7.49B	16.97%29.85B	22.83%8.75B	15.49%7.33B	17.35%7.48B	10.84%6.29B	12.66%25.52B	10.28%7.12B	11.35%6.35B	11.92%6.38B
Gross profit	7.99%5.96B	6.04%24.79B	4.61%6.76B	4.06%6.11B	11.12%6.41B	4.44%5.52B	-3.94%23.38B	-8.93%6.46B	-5.11%5.87B	-3.24%5.77B
Operating expense	-23.15%4.58B	10.74%19.75B	-1.06%4.93B	-1.78%4.41B	1.90%4.46B	49.25%5.96B	-9.38%17.83B	-10.88%4.98B	-6.91%4.49B	-9.98%4.38B
Staff costs	-3.97%1.21B	1.88%5.16B	-5.37%1.32B	3.04%1.22B	10.49%1.36B	0.40%1.26B	0.56%5.07B	3.10%1.4B	0.94%1.19B	-3.68%1.23B
Selling and administrative expenses	-11.41%334M	9.95%3.62B	9.70%2.45B	-2.51%388M	14.78%396M	22.40%377M	-21.47%3.29B	60.24%2.24B	-59.80%398M	-64.90%345M
-Selling and marketing expense	-11.41%334M	0.06%1.58B	-20.57%421M	-2.51%388M	14.78%396M	22.40%377M	-62.24%1.58B	-62.03%530M	-59.80%398M	-64.90%345M
-General and administrative expense	----	19.10%2.03B	----	----	----	----	--1.71B	----	----	----
Research and development costs	-74.14%532M	110.11%3.49B	18.71%679M	-21.34%398M	-12.53%356M	1,068.75%2.06B	99.64%1.66B	78.19%572M	181.11%506M	82.51%407M
Depreciation and amortization	----	-6.84%218M	----	----	----	----	-9.65%234M	----	----	----
-Depreciation	----	-6.84%218M	----	----	----	----	-9.65%234M	----	----	----
Other operating expenses	10.55%2.5B	-4.21%7.27B	-52.77%256M	0.08%2.4B	-1.92%2.35B	0.49%2.27B	-18.99%7.59B	-76.01%542M	-3.15%2.4B	0.67%2.39B
Operating profit	417.43%1.38B	-9.09%5.04B	23.76%1.83B	22.99%1.7B	40.14%1.95B	-133.67%-436M	19.02%5.55B	-1.66%1.48B	1.24%1.38B	26.59%1.39B
Net non-operating interest income (expenses)	20.97%75M	71.86%287M	33.93%75M	73.33%78M	157.14%72M	63.16%62M	15.97%167M	69.70%56M	32.35%45M	-34.88%28M
Non-operating interest income	20.97%75M	71.86%287M	33.93%75M	73.33%78M	157.14%72M	63.16%62M	15.97%167M	69.70%56M	32.35%45M	-34.88%28M
Non-operating interest expense	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net investment income	-188.24%-49M	-15.38%11M	6.59%97M	-106.67%-2M	-63.41%-67M	74.63%-17M	-82.89%13M	42.19%91M	114.29%30M	-173.21%-41M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-1,168.42%-241M	121.60%277M	2,193.33%314M	35.71%-9M	-105.20%-9M	0.00%-19M	226.26%125M	0.00%-15M	6.67%-14M	468.09%173M
Income from associates and other participating interests
Special income (charges)	-500.00%-6M	-1,700.00%-36M	-1,600.00%-34M	0	-1M	-1M	94.87%-2M	85.71%-2M	0	0
Less:Other special charges	500.00%6M	1,700.00%36M	--34M	--0	--1M	--1M	-92.59%2M	----	----	----
Other non-operating income (expenses)	-133.33%-2M	116.53%20M	-63.64%4M	-16.67%5M	103.60%5M	500.00%6M	-503.33%-121M	120.00%11M	-25.00%6M	-1,258.33%-139M
Income before tax	386.42%1.16B	-2.25%5.59B	41.06%2.28B	22.21%1.77B	38.04%1.95B	-132.50%-405M	20.03%5.72B	2.60%1.62B	3.20%1.45B	23.92%1.41B
Income tax	342.24%281M	-17.15%1.47B	0.00%529M	11.85%491M	27.58%569M	-131.87%-116M	27.73%1.78B	20.50%529M	6.81%439M	35.56%446M
Net income	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B	1.71%1.01B	19.18%963M
Net income continuous operations	404.15%879M	4.46%4.12B	61.03%1.75B	26.71%1.28B	42.89%1.38B	-132.77%-289M	16.86%3.94B	-4.31%1.09B	1.71%1.01B	19.18%963M
Noncontrolling interests
Net income attributable to the company	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B	1.71%1.01B	19.18%963M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B	1.71%1.01B	19.18%963M
Gross dividend payment
Basic earnings per share	404.18%31.27	4.42%146.6	60.93%62.33	26.74%45.59	42.78%48.96	-132.74%-10.28	16.87%140.39	-4.25%38.73	1.67%35.97	19.19%34.29
Diluted earnings per share	404.18%31.27	4.42%146.6	60.90%62.3016	26.74%45.59	42.65%48.8985	-132.74%-10.28	16.87%140.39	-4.25%38.7202	1.67%35.97	19.15%34.279
Dividend per share	0	20.00%120	-7.89%70	0	108.33%50	0	108.33%100	216.67%76	0	0.00%24
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall